Publications by authors named "Randall Millikan"

Claim this Profile
T
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study.
Farshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, Rebecca Slack, Randall E Millikan

BMC Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers.
Arlene Siefker-Radtke, Xin-Qiao Zhang, Charles C Guo, Yu Shen, Kathleen F Pirollo, Randall E Millikan

Mol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.
David J McConkey, Woonyoung Choi, Yu Shen, I-Ling Lee, Sima Porten, Randall E Millikan

Eur Urol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study.
Renata Pasqualini, Randall E Millikan, Dawn R Christianson, Marina Cardó-Vila, Wouter H P Driessen

Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma.
Matthew T Campbell, Randall E Millikan, Emre Altinmakas, Lianchun Xiao, Sin Jen Wen

Clin Genitourin Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes.
Bradley J Atkinson, Diana H Cauley, Chaan Ng, Randall E Millikan, Lianchun Xiao

BJU Int· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.
Stephen H Culp, Rian J Dickstein, H Barton Grossman, Shanna M Pretzsch, Sima Porten, Randall E Millikan

J Urol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.
Henry J Conter, Zita D Lim, Chaan S Ng, Randall E Millikan, Nizar M Tannir

Clin Genitourin Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.
Siobhan P Lynch, Yu Shen, Ashish Kamat, H Barton Grossman, Jay B Shah, Randall E Millikan

Eur Urol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience.
Alan J Rodney, Nizar M Tannir, Arlene O Siefker-Radtke, Ping Liu, Garrett L Walsh, Randall E Millikan

Urol Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Ana M Aparicio, Andrea L Harzstark, Paul G Corn, Sijin Wen, John C Araujo, Randall E Millikan

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.
Farshid Dayyani, Bogdan A Czerniak, Kanishka Sircar, Mark F Munsell, Randall E Millikan

J Urol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
Arlene O Siefker-Radtke, Colin P Dinney, Yu Shen, Dallas L Williams, Ashish M Kamat, Randall E Millikan

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.
Lu Wang, Andrea Rotnitzky, Xihong Lin, Randall E Millikan, Peter F Thall

J Am Stat Assoc· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rejoinder to comments on Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.
Lu Wang, Andrea Rotnitzky, Xihong Lin, Randall E Millikan, Peter F Thall

J Am Stat Assoc· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Robert S Svatek, Shahrokh F Shariat, Robert E Lasky, Eila C Skinner, Giacomo Novara, Randall E Millikan

Clin Cancer Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.
Surena F Matin, Vitaly Margulis, Ashish Kamat, Christopher G Wood, H Barton Grossman, Randall Millikan

Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
M Adam Childs, Christopher G Wood, Philippe E Spiess, Labib G Debiane, Mike Hernandez, Randall E Millikan

Can J Urol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
Eric Jonasch, Christopher G Wood, Surena F Matin, Shi-Ming Tu, Lance C Pagliaro, Randall E Millikan

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Arlene O Siefker-Radtke, Ashish M Kamat, H Barton Grossman, Dallas L Williams, Wei Qiao, Randall E Millikan

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
Randall E Millikan, Sijin Wen, Lance C Pagliaro, Melissa A Brown, Brenda Moomey

J Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for advanced prostate cancer: 25 years later.
Christopher J Logothetis, Randall Millikan

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring.
Peter F Thall, Leiko H Wooten, Christopher J Logothetis, Randall E Millikan, Nizar M Tannir

Stat Med· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Peter F Thall, Christopher Logothetis, Lance C Pagliaro, Sijin Wen, Melissa A Brown, Randall E Millikan

J Natl Cancer Inst· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Cora N Sternberg, S Machele Donat, Joaquim Bellmunt, Randall E Millikan, Walter Stadler

Urology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis